TMVR dev 4C Medical raises $9m
BY – MassDevice
Structural heart disease device maker 4C Medical said today it completed a private placement of unsecured convertible promissory notes, raising approximately $9 million to help support development of its transcatheter tech designed to treat mitral regurgitation.
The financing was led by Canadian angel network Anges Québec, the Brooklyn Park, Minn.-based company said.
“We are excited to invest in 4C Medical. With a proven leadership team and a truly novel TMVR technology that eliminates the issues seen with current TMVR technologies, 4C Medical has the potential to addresses a significant unmet need,” Anges Québec investment support VP Stéphane Pilette said in a prepared statement.
Read at MassDevice
